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Maternal alcohol consumption inflicts a multitude of phenotypic consequences that range
from undetectable changes to severe dysmorphology. Using tightly controlled murine
studies that deliver precise amounts of alcohol at discrete developmental stages, our
group and other labs demonstrated in prior studies that the C57BL/6 and DBA/2 inbred
mouse strains display differential susceptibility to the teratogenic effects of alcohol.
Since the phenotypic diversity extends beyond the amount, dosage and timing of alcohol
exposure, it is likely that an individual’s genetic background contributes to the phenotypic
spectrum. To identify the genomic signatures associated with these observed differences
in alcohol-induced dysmorphology, we conducted a microarray-based transcriptome study
that also interrogated the genomic signatures between these two lines based on genetic
background and alcohol exposure. This approach is called a gene x environment (GxE)
analysis; one example of a GxE interaction would be a gene whose expression level
increases in C57BL/6, but decreases in DBA/2 embryos, following alcohol exposure. We
identified 35 candidate genes exhibiting GxE interactions. To identify cis-acting factors
that mediated these interactions, we interrogated the proximal promoters of these 35
candidates and found 241 single nucleotide variants (SNVs) in 16 promoters. Further
investigation indicated that 186 SNVs (15 promoters) are predicted to alter transcription
factor binding. In addition, 62 SNVs created, removed or altered the placement of a CpG
dinucleotide in 13 of the proximal promoters, 53 of which overlapped putative transcription
factor binding sites. These 53 SNVs are also our top candidates for future studies aimed
at examining the effects of alcohol on epigenetic gene regulation.
Keywords: fetal alcohol syndrome, gene x environment interactions, genomics, gene expression, next generation
sequencing, genetic association, epigenetics
INTRODUCTION
Women who drink during pregnancy place their unborn chil-
dren at risk of acquiring clinical features of fetal alcohol syndrome
(FAS) or fetal alcohol spectrum disorder (FASD). FASD encom-
passes all patients displaying some of the clinical features of fetal
alcohol exposure and is much more prevalent than FAS. These
syndromes comprise an array of phenotypes that include: cog-
nitive deficits, intrauterine and post-natal growth retardation,
memory deficits, poor motor skills, facial dysmorphology and
social/behavioral problems. On one end of the spectrum (mild
FASD; ∼1 in 100 live births), children present with mild to
moderate mental deficits that are difficult to diagnose by appear-
ance, while those on the other end (FAS; ∼1 in 1000 live births)
exhibit a readily identifiable facial dysmorphology coupled with a
complement of severe neuropsychological sequelae and neurobe-
havioral deficits (Abel, 1995; Stratton et al., 1996; Sampson et al.,
1997; Jacobson, 1998; Astley et al., 2002; Niwa et al., 2002; Hoyme
et al., 2005; Moore et al., 2007).
Several factors contribute to the phenotypic variability
observed within FAS/FASD, including quantity, frequency and
duration of alcohol exposure (Coles, 1993; Abel, 1995; Maier
and West, 2001; May et al., 2013), developmental stage at the
time of consumption and underlying maternal factors and/or
genetic background influences, as only 5–10% of women with
a positive drinking history give birth to children displaying fea-
tures of FASD (Abel, 1995; Stratton et al., 1996). Furthermore,
monozygotic twins display phenotypes that are more similar than
dizygotic twins, suggesting that genetic background affects the
incidence of FAS/FASD (Christoffel and Salafsky, 1975; Chasnoff,
1985; Streissguth and Dehaene, 1993; Riikonen, 1994). In addi-
tion, allelic variation within the alcohol dehydrogenase gene,
ADH1B, can lead to varying teratogenic outcomes in different
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ethnic groups (Warren and Li, 2005). These reports support
the hypothesis that environmental elements, plus an individ-
ual’s genetic background, contribute significantly to his or her
susceptibility to the teratogenic effects of alcohol.
There are challenges to studying the pathogenesis of FAS/FASD
in the human population; the clinical drinking history is not
always complete or reliable, and it is unethical to conduct fetal
alcohol studies in humans. To address these challenges, several
groups performed studies describing the morphological changes
that occur following alcohol exposure in various strains of mice.
Two inbred mouse strains, C57BL/6 and DBA/2, differ widely
in their response to maternal consumption of alcohol (Gilliam
et al., 1988; Goodlett et al., 1989; Ogawa et al., 2005; Downing
et al., 2009, 2012; Chen et al., 2011; Zhou et al., 2011). Previous
studies by our group demonstrated that while DBA/2 animals
are resistant to the teratogenic effects of fetal alcohol exposure in
embryonic cultures, C57BL/6 mice are quite susceptible, exhibit-
ing phenotypic abnormalities that affect embryonic lethality,
brain morphology, fetal weight gain, behavior, as well as for-
mation of the digits, skeleton, eyes, kidneys and heart (Ogawa
et al., 2005; Chen et al., 2011; Zhou et al., 2011). Using a whole
embryo culture approach that strictly controls the timing and
dose of alcohol exposure, without interference from the mater-
nal environment, we demonstrated that genetic background was a
driving factor in the teratogenicity of alcohol in C57BL/6 embryos
(Ogawa et al., 2005; Chen et al., 2011).
In this report, we sought to better understand the underly-
ing genomic vulnerabilities to the teratogenic effects of alcohol
observed between C57BL/6 and DBA/2 cultured embryos. We
hypothesized that by strictly controlling confounding physiolog-
ical factors (i.e., the maternal environment, intrauterine position
effects, etc.), these studies would identify underlying genetic dif-
ferences between C57BL/6 and DBA/2 that contribute to the
observed differential vulnerability to the teratogenic effects of
alcohol. Furthermore, we proposed that polymorphisms between
C57BL/6 and DBA/2 in regulatory elements and other factors
that influence RNA expression are responsible for much of these
morphological differences. We used a two-pronged approach that
takes advantage of the strain-specific genomic signatures and
gene expression profiles to identify candidate cis-regulatory ele-
ments with the potential to drive differential expression between
C57BL/6 and DBA/2 embryonic cultures. First, we used a gene
x environment (GxE) approach to identify transcripts that were
affected by both genetic background (i.e., C57BL/6 vs. DBA/2)
and alcohol exposure (presence vs. absence of alcohol) to iden-
tify genes that are candidates for the morphological diversity
between the these two inbred strains following exposure of
equimolar ratios of alcohol in cultured embryos. Since the GxE
approach identifies differentially expressed genes that are candi-
dates for mediating the interaction, we then sought to uncover
underlying single nucleotide variants (SNVs) in cis-regulatory
elements within the proximal promoters of these candidate genes.
SNVs within the promoters are excellent candidates for regulat-
ing expression of the nearby altered genes, as regulatory SNVs
can alter the location and function of enhancers and promot-
ers (De Gobbi et al., 2006) that change transcriptional levels
(Munkhtulga et al., 2010) in specific cell types (Poitras et al.,
2010) and lead to allele-specific changes in expression (Azad et al.,
2013). SNV studies narrowed the list to 16 genes that showed
both a GxE interaction based on gene expression studies and
an SNV driven to fixation in opposite directions in the proxi-
mal promoter. Pathway analysis of this set of genes enhanced the
understanding of the pathophysiology of alcohol exposure. Lastly,
we investigated how these SNVs may lead to altered DNA methy-
lation and transcription factor binding, with 53 SNVs potentially
affecting bothDNAmethylation and transcription factor binding.
This study provides a framework for future experiments aimed
at understanding the combinatorial effects of these SNVs on sus-
ceptibility to FAS/FASD, and these two strains provide a tractable
model system for identifying the complement of genetic loci and
epigenetic events that contribute to the teratogenesis that occur
along the spectrum of FAS/FASD.
MATERIALS AND METHODS
MOUSE STRAINS USED IN THIS STUDY
The Harlan strains used in the microarray study (C57BL/6NHsd
and DBA/2NHsd), as well as the lines used to identify
the potential regulatory SNVs (C57BL/6NJ and DBA/2J),
descended from the original C57BL/6J (http://jaxmice.jax.org/
strain/000664.html) and DBA/2J (http://jaxmice.jax.org/strain/
000671.html) lines created at The Jackson Laboratories (Zurita
et al., 2011). The C57BL/6 founder line originated from one of
Abbie Lathram’s fancy mouse stocks in 1921 by CC Little, and was
maintained by brother-sister mating at the Jackson Laboratories
until 1951 (at generation F32), when a sub-line, designated
C57BL/6N, was sent to the NIH (Zurita et al., 2011). This sub-
line is a founder line for C57BL/6NHsd and C57BL/6NJ. Harlan
acquired these animals from the NIH in 1983 and has main-
tained them continuously in their colony; this sub-line is desig-
nated C57BL/6NHsd (order code 044; http://www.harlan.com).
The C57BL/6NJ (http://jaxmice.jax.org/strain/005304.html) sub-
line consists of embryos that were frozen at the NIH in 1997
and sent back to the Jackson Laboratory in 2005. The Jackson
Laboratory thawed this line, expanded it and froze it down imme-
diately. New stock animals are continually thawed to maintain
the genetic integrity of the C57BL/6NJ sub-line. CC Little started
inbreeding DBA/2 mice in 1909, and DBA/2J animals have been
maintained continuously at The Jackson Laboratories. A sub-
line (DBA/2N) was sent to the NIH in 1951 (at generation F34).
Harlan later acquired this line, designated DBA/2NHsd (order
code 042; http://www.harlan.com).
ALCOHOL EXPOSURE IN EMBRYONIC CULTURES
All experimental procedures were approved by the Institutional
Animal Care andUse Committee of the Indiana University School
of Medicine (Indianapolis, IN) and are in accordance with the
guidelines of the Institutional Animal Care and Use Committee
of the National Institute on Drug Abuse, National Institutes of
Health, and the Guide for the Care andUse of Laboratory Animals
(National-Academy-of-Sciences, 2010).
Previous studies from our lab measured the phenotypic vari-
ations between the C57BL/6 and DBA/2 inbred strains resulting
from alcohol exposure in embryonic cultures (Ogawa et al., 2005;
Chen et al., 2011). The technique for whole embryo culture was
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described previously (Ogawa et al., 2005), based on methods
by New (New, 1978). Briefly, 2-month-old C57BL/6NHsd and
DBA/2NHsdmice fromHarlan, Inc. (Indianapolis, IN) were indi-
vidually housed and acclimated for at least 1 week prior tomating.
Two females were placed with one male of the same strain for 2 h.
When a vaginal plug was detected after the mating period, it was
designated as embryonic day 0 (E0). On E8.25, females were sac-
rificed by CO2 asphyxiation for morphological and transcriptome
studies.
The alcohol exposure paradigm that yielded the highest degree
of differential vulnerability was used for gene expression analy-
sis (Chen et al., 2011). The gravid uterus was removed at 37◦C;
each embryo, plus the visceral yolk sac and a small piece of the
ectoplacental cone, was carefully removed. Three embryos from
each C57BL/6NHsd or DBA/2NHsd dam, bearing 3–5 somites
(∼E8.25, age of the embryos is determined by the somites),
were collected. Four groups of embryos, C57BL/6NHsd with
or without alcohol and DBA/2NHsd with or without alcohol
(n = 6 each) were incubated in 20mL of medium, consisting
of 70% immediately centrifuged heat-inactivated rat serum and
30% phosphate buffered saline supplemented with 20 units/ml
penicillin and 20 units/ml streptomycin (Sigma, St. Louis, MO).
Culture bottles were gassed for 2 h with 5%O2, 5% CO2 and 90%
N2 in a rotating culture system (B.T.C. Precision Incubator Unit,
B.T.C. engineering, Cambridge, England, 36 rpm). After a 1–2 h
acclimation period, a 6 h treatment was initiated by incubating
embryos in fresh medium with or without 88mM ethanol in iso-
tonic buffer. After the 6-h alcohol treatment, all embryos were
transferred to alcohol-free culture media for 15–16 h, for a total
of 24 h in culture. The 6 h exposure allows a precise delineation
of the developmental time period in which various teratogenic
effects can be induced, which facilitates a rigorous examination
of the temporal windows of vulnerability (Chen et al., 2011).
In previous studies, we demonstrated distinct morphological
differences between these two lines following 44 h of contin-
uous ethanol treatment (Ogawa et al., 2005) and 42 h after a
6 h ethanol treatment (Chen et al., 2011). In both studies, the
C57BL/6 embryonic cultures were more susceptible to the ter-
atogenic effects of alcohol than the DBA/2 animals. However,
the two lines showed some differential dysmorphology after alco-
hol exposure. For example, C57BL/6 animals showed increased
developmental delay compared to DBA/2 animals, although both
are delayed compared to controls (Chen et al., 2011). In the
same study, we cataloged the embryonic structures that showed
morphological evidence of developmental delay in C57BL/6 and
DBA/2 cultures. For example, dysmorphology is prominent in
the heart, forebrain, midbrain, hindbrain, caudal neural tube,
optic vesicle and hindlimb in C57BL/6 cultures, but restricted to
the forebrain and optic vesicle in DBA/2 cultures. Furthermore,
C57BL/6 embyros contained a large number of cleaved(c)-caspase
3 positive (+) cells (i.e., apoptotic cells) in the optic vesicles, sev-
eral brain regions, the craniofacial primordial, as well as cranial
nerve nuclei V, VII, VIII, and IX following alcohol exposure. In
contrast, alcohol-exposed DBA/2 embryos only contained a small
number of c-caspase 3+ cells (Chen et al., 2011).
In the present study, our goal was to capture the transcriptome
changes that occur prior to development of the morphological
changes in order to gain an understanding of the genetic path-
ways that are targeted by alcohol exposure, not necessarily the
alterations in expression that occur after manifestation of the
dysmorphology. We hypothesized that collecting embryos at 15–
16 h post-alcohol treatment would give the culture system time
to eliminate the alcohol and reduce potential alcohol-induced
artifacts. Therefore, all cultures were terminated 24 h after the
start of alcohol treatment to reveal the upstream genetic path-
ways. Embryos were alive at termination, which was confirmed
by observing a beating heart and circulating blood in the yolk
sac. We conducted morphological examinations of the embryos
at embryonic day (E) 8.25 (when culture initiated), +1 day in
culture (i.e., E8.25 + 1); E8.25 + 1 is analogous to an embryo
examined at E9.0. We observed several morphological changes in
the embryos, which are analogous to those observed at the later
time points (Ogawa et al., 2005; Chen et al., 2011). In all cases,
the C57BL/6NHsd embryos demonstrated more morphological
changes and developmental delay compared to the DBA/2NHsd
strain. In addition, we noticed two distinct subtypes of embryos
in C57BL/6NHsd cultures. Approximately 50% of the ethanol-
treated C57BL/6NHsd cultures still had an open neural tube. This
could be due to delayed embryonic development or to the terato-
logical effects of alcohol. Therefore, we stratified the embryonic
cultures into two subtypes, neural tube closed (NTC) and neural
tube open (NTO) in an attempt to capture distinct genetic dif-
ferences potentially caused by alcohol. All control embryos from
both genotypes (C57BL/6NHsd and DBA/2NHsd) had a closed
neural tube. Following alcohol treatment, we observed that the
majority of the DBA/2NHsd embryos also had a closed neural
tube. However, the neural tube failed to close in a small num-
ber of DBA/2NHsd and ∼50% of the C57BL/6NHsd embryos,
resulting in an NTO morphology. Therefore, we subclassified
each embryo into NTO and NTC bins. Embryos were segregated
into six subtypes based on neural tube dysmorphology (NTO vs.
NTC), inbred strain (C57BL/6NHsd or DBA/2NHsd) and alco-
hol exposure [with EtOH vs. without (Ctrl)]: NTO-B6-EtOH,
NTC- B6-EtOH, NTC-B6-Ctrl, NTO-D2-EtOH, NTC-D2-EtOH
and NTC-D2-Ctrl, where B6 indicates C57BL/6NHsd and D2
designates DBA/2NHsd. Formore strict and detailed comparison,
we analyzed the NTC and NTO embryos separately compared to
their respective NTC control embryos. Due to the small numbers
of NTO embryos in the DBA/2NHsd background, a large number
of DBA/2NHsd animals were used in this study.
AFFYMETRIX GENE EXPRESSION
The comparative expression studies presented here were con-
ducted on heads instead of whole embryos to focus on the cranial
neural crest and brain. At this stage (∼E9.0), further dissection
of parts of the head or brain would not yield enough tissue
for microarray studies. The head of each embryo was dissected
above the otic vesicle, immediately immersed in 0.7ml TRIzol
(Invitrogen, Carlsbad, CA) and homogenized to extract total
RNA for RT-PCR and microarray studies. Total RNA was isolated
from 36 individual embryos (6 vehicle control, 6 NTC alco-
hol treated and 6 NTO alcohol treated per strain) as previously
described (Zhou et al., 2011). The quality of RNA was assessed
by the Agilent Bioanalyzer (Agilent Technologies, Waldbronn,
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Germany) and by spectrophotometry (220 nm to 350 nm); con-
centration was determined from the values at A260. Microarray
hybridizations and bioinformatics analyses were performed at the
Center for Medical Genomics at the Indiana University School
of Medicine. Labeling and hybridization to Affymetrix Mouse
Genome 430A GeneChips® (Affymetrix, Santa Clara, CA) were
carried out following the manufacturer’s suggested procedure.
The Mouse Genome 430A chip contains over 22,600 probe sets
representing transcripts and variants from over 14,000 well-
characterized mouse genes. Fragmented biotinylated RNA from
each embryo was hybridized to its own GeneChip for 17 h at
42◦C. We previously demonstrated that the microarray analy-
sis revealed striking differences between the embryos with open
neural tubes (EtOH-NTO) and those with closed neural tubes
(EtOH-NTC) (Zhou et al., 2011). Control embryos had closed
neural tubes. Therefore, the transcriptome analysis was con-
ducted based on the embryonic morphological phenotype.
The data from independent arrays (each with RNA from
a single embryo) for each treatment were extracted using the
AffymetrixMicroarray Suite 5.0 (MAS5) algorithm. Data for both
experiments have been deposited in GEO/NCBI and have been
assigned series accession number GSE9545 and sample num-
bers GSM241642 throughGSM241660. Tominimize false positive
results, only genes detected (“present” by the MAS5 algorithm)
on at least half of all individual arrays in at least one experimental
condition were retained for further analysis. This avoids data that
primarily represent noise (McClintick and Edenberg, 2006).
B6 AND D2 GENOMIC SEQUENCE
We remapped the recently established genomic sequence avail-
able at the European Nucleotide Archive (http://www.ebi.ac.
uk/ena/) for both C57BL/6NJ (http://www.ebi.ac.uk/ena/data/
view/ERS076384&display=html) and DBA/2J (http://www.
ebi.ac.uk/ena/data/view/ERS075663&display=html) onto release
66 of the M. musculus genome from Ensemble (http://www.
ensembl.org) using CLC Genomics Workbench V4.7 (http://
www.clcbio.com). We then called SNVs using the quality based
variant detection tool with the neighborhood radius set to 5,
maximum gap and mismatch count set to 2, minimum neigh-
borhood quality of PHRED 15, and minimum central quality of
PHRED 20. Variants in non-specific regions were ignored. Across
all reads, a minimum variant frequency greater than 10% was
required.
GENE X ENVIRONMENT (GxE) INTERACTIONS
The transcriptome of these lines, as impacted by alcohol exposure,
was quantified by microarray analysis. We designed this experi-
ment to analyze expression based on embryo neural tube dysmor-
phology (NTO and NTC), genetic background (C57BL/6NHsd or
DBA/2NHsd) and alcohol exposure (88mm EtOH or vehicle) in
six groups as indicated in the experimental design above. Five
embryos from each category were used for microarray studies.
Since there were no control animals with the neural tube open
morphology, all NTO studies used the control-NTC animals for
comparison.
We analyzed the data using the Affymetrix Expression
Console 1.1.2800.19935. Intensities were normalized
using quantile normalization and the adjusted data were
analyzed using the probe logarithmic intensity error
(PLIER) method. According to the Affymetrix manual
(http://media.affymetrix.com/support/technical/technotes/plier_
technote.pdf). The PLIER method produces a more accurate probe
set signal by employing feature responses to interpret intensity
data, dynamic weighting by empirical feature performance, and
handling error appropriately across low and high target abundance.
The results from the PLIER analysis were variance stabilized
using log2 transformation and analyzed by gene for significant
differences using a 2 factor analysis of variance adjusted for
multiple testing with a false discover rate of 5% (Benjamini
and Hochberg, 1995). The main effects were line (DBA/2J vs.
C57BL/6NHsd) and exposure to alcohol. Of primary interest
were those genes where a differential response to alcohol was
dependent on the line, i.e., differential expression in response to
alcohol is dependent on the genetic background.
IDENTIFYING CANDIDATE SNVs
Since the C57BL/6NHsd and DBA/2NHsd genomes are not
available, we chose closely related sub-strains (C57BL/6NJ and
DBA/2J) for the genomic analyses. To define potential SNVs
driving the differential phenotype following alcohol exposure,
we cataloged all SNVs between C57BL/6NJ and DBA/2J located
within 5 kb upstream of the transcriptional start site(s) of each
candidate gene. To define a SNV, we calculated the difference
in allele frequency for the same allele between C57BL/6NJ and
DBA/2J, and concentrated on alleles driven to opposite fixation.
SNVs were defined as alleles that were fixed at ≥0.90 (i.e., the
frequency was ≥90% in one strain and ≤10% in the other). To
identify putative transcription factor binding sites, we retrieved
20 bp of flanking sequence (10 bp on each side of the SNV; 21 bp
total) from the NCBI37/mm9 mouse genome assembly, and put
the sequence into PROMO (http://alggen.lsi.upc.es/) (Messeguer
et al., 2002; Farre et al., 2003). PROMO uses version 8.3 of
Transfac (Knuppel et al., 1994; Wingender, 2008) to identify
putative transcription factor binding sites. For genes expressed
from the Watson strand, we used the published sequence; for
genes expressed on the Crick strand, we used the reverse com-
plement. This ensured that we analyzed the same strand that
the transcriptional machinery uses to transcribe the gene. The
C57BL/6NJ and DBA/2J sequences were analyzed separately for
putative transcription factor binding sites and additions or loss of
CpG dinucleotides.
RESULTS
LINE-SPECIFIC DIFFERENCES IN GENE EXPRESSION
We first compared gene expression profiles between all
C57BL/6NHsd and all DBA/2NHsd cultured embryos with-
out taking alcohol exposure into consideration. We combined
all C57BL/6NHsd embryos with an NTC morphology, which
included those exposed and not exposed to alcohol, and com-
pared them to the DBA/2NHsd embryos with a NTC phenotype,
including those exposed and not exposed to alcohol. We repeated
this study with embryos displaying NTO. However, in this anal-
ysis, the controls had a NTC phenotype, as none of the control
animals displayed an NTO morphology. This analysis was used
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to determine the subset of genes that are differentially expressed
between the two lines. Using a false discovery rate (FDR) of 5%
(Benjamini and Hochberg, 1995), we identified 1143 genes that
were differentially expressed in NTC embryos and 1164 genes
that were differentially expressed in NTO embryos, for a total
of 1403 differentially expressed genes between these two inbred
strains (Figure 1A). In these two independent experiments, 904
differentially expressed transcripts were detected in both the
NTC and NTO embryos; ∼718 are significant at an FDR of
∼10−5. To confirm that these demonstrate statistical significance,
we performed a hypergeometric distribution and a binomial
distribution. Using a hypergeometic distribution, we found that
the probability of drawing 904 genes that would be in the union
by chance with independent draws is less than 0.015. A more
informative metric might be the number one would expect by
chance. This can be approximated with the binomial distribution
because the numbers are large, i.e., sampling with replacement
gives probabilities similar to sampling without replacement.
The proportion of genes found significant in each experiment
was 0.0327 and 0.0324 respectively. With independence, the
proportion expected in the union is 2(0.0327) (0.0324) × 35,561
= 75. We observed about 12 times that number.
Many genes in this cohort are key to the development of
the nervous system including: channel proteins and receptors,
e.g., Kcnmb1 (potassium large conductance calcium-activated
channel), Chrnb1 [cholinergic receptor, nicotinic, beta polypep-
tide 1 (muscle)]; neural transcription factors and homeobox
genes, e.g., Nkx1-2 [NK1 transcription factor related, locus 2
(Drosophila)], Igf1 (insulin-like growth factor 1),Gbx2 (gastrula-
tion brain homeobox 2), Sox21 (SRY (sex determining region Y)-
box 21); epigenetic components, e.g., Hist1h2ab (histone cluster
1, H2ab), Setd7 (SET domain containing lysine methyltransferase
7); heat shock proteins, e.g., Dnajc13, Dnajc21 DnaJ (Hsp40)
homolog, subfamily C, member 13 and 21; genes involved in
apoptosis, e.g., Bnip3l (BCL2/adenovirus E1B interacting protein
3-like), Gadd45gip1 (growth arrest and DNA-damage-inducible,
gamma interacting protein 1), E2f5 (E2F transcription factor 5);
and structural proteins, Bean1 (brain expressed, associated with
Nedd4, 1), Tuba3a (tubulin, alpha 3A), Optc (opticin).
Furthermore, Ingenuity Pathway Analysis (IPA; Ingenuity®
Systems, www.ingenuity.com) of this set of 904 genes found in
both the NTC and NTO experiments indicates that the most
significant pathways are: inflammatory response; cell death and
survival; energy production; lipid metabolism; embryonic devel-
opment; and cancer, hematological disease. We picked three net-
works as examples. The genes delineating these networks are listed
in Table 1.
Notably among the 1403 differentially expressed genes, a num-
ber of microRNAs were identified: miR206, miR31, miR463,
miR551b, miR669a-2, miR142, miR211, miR22, miR27b, miR326,
miR429, miR488, miR672, miRlet7a-2, miRlet7d, miRlet7e, miR-
let7i, miR330, miR683-1. Many of thesemiRNAs display functions
relevant to development. For example miR-142 regulates the
formation and differentiation of hematopoietic stem cells in ver-
tebrates (Lu et al., 2013). miR-31, which plays multiple roles
during development and in cancer progression, is over expressed
in myoblasts from patients with Duchene Muscular Dystrophy,
FIGURE 1 | Summary of the differentially expressed genes.
(A) Line-specific differences in gene expression. We conducted this
analysis in two separate experiments that captured two embryonic
phenotypes: neural tube closed (NTC) and neural tube open (NTO). This
analysis was conducted by examining the gene expression changes solely
between C57BL/6NHsd and DBA/2NHsd; alcohol exposure is not taken into
consideration. Therefore, in the NTC group, all C57BL/6NHsd embryos
(with and without alcohol) were measured as one cohort, while the
DBA/2NHsd embryos (with and without alcohol) comprised the second
group. The NTO cohort was analyzed in the same manner. This depicts the
innate changes in gene expression between the two genetic backgrounds,
plus the changes that are due to alcohol exposure, but cannot assess if
there are interactions between the genetic background and alcohol
exposure. There are 1403 genes that are differentially expressed between
the C57BL/6NHsd and DBA/2NHsd embryos; 904 of these are differentially
expressed in both the NTO and NTC studies. (B) Differential gene
expression as result of genetic and alcohol interactions (GxE). As above, we
analyzed gene expression in the NTC and NTO cohorts separately. In this
study, we measured the potential interactions between alcohol exposure
and genetic background. We found 22 genes that demonstrated GxE
interactions in the NTC group and 13 genes showing GxE interactions in the
NTO group. (C) Genes subject to GxE Interactions. The genes subject to
GxE interactions are delineated.
compared to control individuals (Cacchiarelli et al., 2011) and
thought to act as an inhibitor of metastasis in breast cancer cells
(Valastyan et al., 2011). While miR-206 regulates angiogenesis in
zebrafish (Stahlhut et al., 2012) the miRlet7 family is essential for
cell fate determination in C. elegans (Reinhart et al., 2000) and has
been implicated in impairment of tumorigenesis (Johnson et al.,
2005; Kumar et al., 2008). Finally, miR-27b regulates CYP1B1
expression post-transcriptionally in cancer tissues (Tsuchiya et al.,
2006; Chuturgoon et al., 2014).
DIFFERENTIAL GENE EXPRESSION AS RESULT OF GENETIC AND
ALCOHOL INTERACTIONS (GxE)
To further understand the genes that are responsive to alcohol
and display a genetic basis, we determined which transcripts
showed an interaction between these two conditions (i.e., a gene
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Table 1 | Networks of NTO/NTC overlapping genes between C57BL/6NHsd and DBA/2NHsd.
Molecules in network Score # Target genes Top diseases and functions
Ager, Atp5f1, Atp5g2, B3gnt2, Bcl2l14, Ccl19,
Ccl21, Ccl27, Clcn7, Cyba, Epx, Fgf18, Gfi1, Gipc1,
Gp49a/Lilrb4, Gzmk, Hmgb2, Itgb1bp1, Metap2,
Mgat3, Mkl2, Nod1, Ntsr2, Oscp1, Ppp2r2d, Prg3,
S100a1, S100a9, Smg1, Sytl1, Tff2, Tpm4
50 32 Inflammatory Response, Cellular
Function and Maintenance, Cellular
Movement
Akt2, Arhgap23, Atf6, Birc6, Camkk1, Chkb,
Cox7a2l, Dcps, Ddx24, Dennd4a, Gapdh, Hmgb1,
Hpcal1, Kdelr1, Map3k5, Myef2, Pank2, Prex1,
Smek2, Smndc1, Stxbp4, Syncrip, Tinf2, Tomm22,
Vdac3, Vps28, Ywhaq, Znrf2
40 28 Cellular Compromise, Cellular
Function and Maintenance, Cell Death
and Survival
Actg2, Anapc1, Blvra, Cdc23, Cml3, Cpd, Cxxc4,
Daz2, Dlx5, Dvl1, Ercc4, Gde1, Hbg2, Hmbs,
Hsd3b4, Kirrel, Let-7, Mir-204, Runx2, Sbf1, Sfrp4,
Smad4, Sprr1a, Tob2, Trim32
34 25 Embryonic Development, Organ
Development, Organismal
Development
x environment (GxE) interaction). We compared the ethanol-
treated animals with a NTC subtype from each genotype to their
respective NTC controls. However, since none of the control ani-
mals had an NTO phenotype, NTC embryos from the same strain
were used as a control, as follows: the Control-NTC vs. Alcohol-
NTC group and the Control-NTO vs. Alcohol-NTO group.
Accepting an FDR of 5%, we identified 35 candidates that demon-
strate a GxE interaction; 22 were in the NTC subtype and 13 were
in the NTO subtype (Figures 1B,C). IPA studies indicate that the
top networks are cancer; respiratory disease; cell-to-cell signaling;
gene expression; cell death and survival; and cellular compromise
(Table 2). These 35 genes are top candidates underlying the diver-
gent morphological changes observed between C57BL/6Hsd and
DBA/2Hsd embryonic cultures that were exposed to alcohol.
Genes exhibiting a GxE interaction show not only differen-
tial expression, but also opposite patterns of expression that are
dependent upon treatment. For example, in NTC embryos, Eya2
[eyes absent 2 homolog (drosophila)] expression changes from
an average of 7.26 ± 0.045 in control C57BL/6NHsd embryos
to 7.52 ± 0.004 in ethanol-treated embryos. Conversely, con-
trol DBA/2NHsd embryos show an expression value of 7.63 ±
0.007, which drops to 7.40 ± 0.04 following incubation in alco-
hol (Figure 2). The Affymetrix PLIER expression levels are shown
on the Y-axis. The black circles represent gene expression levels
in control embryos, while the triangles represent gene expres-
sion levels in the alcohol-treated animals. There is a clear inverse
correlation between the two genotypes following exposure to
alcohol, as expression of Eya2 increases following treatment in
C57BL6NHsd embryos, while it decreases in DBA/2Hsd embryos.
We plotted the GxE interactions for the remaining genes.
Twelve of the NTC genes (Csmd3, Cxadr, D5ert577e, Eno2,
Mageb18, Olfr1248, Olfr148, Rhoc, Rpl36a, Tspan2, Vmn1r37, and
7402416P09Rik) showed strong GxE interactions (Supplemental
Data, Figure S1), as measured by an intersecting line demonstrat-
ing inverse correlation with gene expression; in a weak interac-
tion, the lines do not intersect, while nine NTC genes (Fam174b,
Marveld2, Mcat, Nudt8, Pdxp, Tac2, Zfp157, 4930579K19Rik, and
B230319C09Rik) showed weak GxE interactions (Supplemental
Data, Figure S1). Eleven of the NTO genes (Apold1, Eya4,
Kera, Leo1, Olfr312, Olfr975, Psme4, Qars, Snord38a, Tnfrsf22,
and Vps51) showed strong GxE interactions and two (Pkm2
and Vipr1) showed weak GxE interactions (Supplemental Data,
Figure S2).
One concern for gene expression studies using microarrays
is whether or not there is inherent expression bias due to
SNVs within the probe-sets that hamper binding. This is poten-
tially exacerbated when comparing changes in expression from
a strain that is closely related to the reference sequence (i.e.,
C57BL/6NHsd) to a strain that is more distantly related (i.e.,
DBA/2NHsd). A hallmark of biased expression would be a con-
sistent observation of decreased signal from the DBA/2NHsd ani-
mals in transcripts harboring SNVs in the probe-sets. In Figure 2,
the DBA/2NHsd animals show higher levels of Eya2 expres-
sion under control conditions. Therefore, it is highly unlikely
that SNVs within the Eya2 probe-sets are causing biased detec-
tion. Examination of the remaining GxE genes shows that 3/35
genes demonstrating GxE interactions potentially exhibit biased
expression; Mcat and Zfp157, which were detected in NTC ani-
mals (Figure S1), and Pkm2, which was detected in NTO studies
(Figure S2), are expressed at lower levels in DBA/2NHsd embryos
under both conditions. Examination of the probe-sets for these
three genes indicates that there is low likelihood that SNVs
within the probe-sets account for the decreased expression in
DBA/2NHsd cultures. There are 25 probe-sets that span Mcat; 2
of these harbor SNVs. Similarly, 23 probe-sets span Zfp157, 2 of
which have SNVs. Pkm2 has 15 probesets, but non-contain any
informative SNVs.
GENOMIC SIGNATURES OF THE DIFFERENTIALLY EXPRESSED GxE
GENES
To better understand the genetic basis driving these GxE inter-
actions, we systematically identified the single nucleotide vari-
ants (SNVs) between C57BL/6 and DBA/2 using a genomics
approach. However, the strains used for the microarray
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Table 2 | Genes Demonstrating a GxE Interaction with Associated SNVs in the Promoter.
Gene Name Function Expression during
mouse development
Relevance to neural
development
References
Eya2 Eyes Absent Homolog2
(Drosophila)
Tyrosine phosphatase,
transcription activator
Cranial placodes,
branchial arches and CNS
during organogenesis
Regulate preplacedal
ectoderm (PPE)
differentiation
Xu et al., 1997;
Grifone et al.,
2007; Sato et al.,
2010
Csmd3 CUB and Sushi multiple
domains 3
Hydrolyzing O-glycosyl
compounds
E14.5 to
adult—Cardiovascular
and nervous system
(mainly in human adult
and fetal brains)
Candidate gene for Autism
Spectrum Disorders
(ASDs)
Shimizu et al.,
2003; Floris et al.,
2008
Mcat Malonyl CoA:ACP
Acyltransferase
(Mitochondrial)
Transfer a malonyl group
from malonyl-CoA to the
mitochondrial acyl carrier
protein
E14.5 by RT-PCR N/A Smith et al., 2012
Tac2 Tachykinin-2 Neural peptide signaling E11.5 to adult—CNS May involve pain
modulation
Mar et al., 2012
Vps51 Vacuolar protein sorting 51 Transport of endosomes
to the trans-Golgi
network (TGN)
N/A N/A Skarnes et al., 2011
Apold1 Apolipoprotein L Domain
Containing 1
Angiogenesis and
activity-dependent
changes of brain
vasculature
E14.5—Heart ventricle May affect blood-brain
permeability
Diez-Roux et al.,
2011; Zhou et al.,
2013
Leo1 Paf1/RNA Polymerase II
Complex Component
Gene transcription
regulation and chromatin
remodeling
E9.5, E11.5, and
E14.5—urogenital
system
Cardiac and neural crest
development in zebrafish
Wertz and
Herrmann, 2000
Psme4 Proteasome (Prosome,
Macropain) Activator
Subunit 4
Proteasome activator,
involves in histone
degradation and DNA
damage response
E14.5—Nervous system,
sensory organs,
alimentary system, and
skeletal system
N/A Ustrell et al., 2002;
Qian et al., 2013
Vipr1 Vasoactive Intestinal
Peptide Receptor 1
VIP receptor, modulated
by G-proteins
E12-E18.5 by RT-PCR;
detected at
E13.5—cerebral cortex;
Adult rat: cerebral cortex
and hippocampus
Promote neuronal survival Delgado et al.,
1996; Fabricius
et al., 2011
Fam174b Family with Sequence
Similarity 174, Member B
Membrane protein of
unknown function
E14.5—alimentary
system, limbs, head,
skeleton system,
sensory organs
Deleted in a patient with
behavioral disturbance,
autism, and epilepsy.
Diez-Roux et al.,
2011; Sarahan
et al., 2011; Kamien
et al., 2014
Mageb18 Melanoma-associated
antigen B18
Infection, inflammation,
regulation of cell
proliferation and
apoptosis
Post-natal brain, testis
and adipose tissue
N/A Diez-Roux et al.,
2011; Lin et al.,
2012
Pdxp Pyridoxal (pyridoxine,
vitamin B6) phosphatase
Vitamin B6 Metabolism
Required for normal
progress through mitosis
and normal cytokinesis.
E14.5—Nervous system,
sensory organs,
cardiovascular system,
alimentary system
Activates cofilin through
dephosphorylation
Niwa et al., 2002;
Jang et al., 2003
(Continued)
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Table 2 | Continued
Gene Name Function Expression during
mouse development
Relevance to neural
development
References
Rpl36a 60S ribosomal protein
L36a
Structural constituent of
ribosome
E2 to E4.5—blastocyst
E12.5 to E18.5—brain
Down-regulated in spinal
cord of Amyotrophic
Lateral Sclerosis (ALS)
model
de Oliveira et al.,
2013; MGI
database
Tspan2 Tetraspanin-2 Regulation of cell
development, activation,
growth and motility
E14.5—pituitary
Post-natal—CNS
Involved in early
differentiation of
oligodendrocytes
Birling et al., 1999;
Diez-Roux et al.,
2011
Zfp157 Zinc finger protein 157 Stat6-regulated KRAB
domain zinc finger
protein, binds DNA and
regulate transcription
E8.5—head fold, neural
tube at
mid-gestation—brain,
neural tube, mammary
placodes, limbs
Oliver et al., 2013
Snord38a Small nucleolar RNA, C/D
Box 38A
2′O-ribose methylation of
RNA
N/A N/A Nicoloso et al.,
1996
FIGURE 2 | Eya2 demonstrates a strong GxE interaction. The Affymetrix
PLIER expression levels are shown on the Y-axis. The black circles represent
gene expression levels in control embryos, while the triangles represent
gene expression levels in the alcohol-treated animals. Two conditions are
measured in this experiment, gene expression levels in controls and gene
expression levels in EtOH-treated animals. The blue line depicts the
changes in gene expression found between the C57BL/6NHsd control
embryos (black circle) and their EtOH-treated test embryos (black triangle).
The red line depicts the changes in in gene expression found between the
DBA/2NHsd control embryos (black circle) and their EtOH-treated test
embryos (black triangle). The interaction is depicted by showing an inverse
correlation between the gene expression profiles of the two inbred strains.
study (C57BL/6NHsd and DBA/2NHsd) were raised at Harlan
and have not been added to the mouse sequence database.
The closest matches in the mouse database are C57BL/6NJ
(Yalcin et al., 2012) and DBA/2J. Therefore, we delineated
the SNVs between C57BL/6NJ and DBA/2J in the promot-
ers (5 kb upstream of each transcriptional start site) of all
35 genes showing GxE interactions. We found that 16 of
these genes contain SNVs between C57BL/6NJ and DBA/2J:
Eya2, Csmd3, Mcat, Tac2, Vps51, Apold1, Leo1, Psme4, Vipr1,
Fam174b, Megab18, Pdxp, Rpl36a, Tspan2, Zfp157, and Snord38a
(Table 2). A number of olfactory receptor genes were also iden-
tified, but were placed on the backburner since they display
high sequence identity among orthologs, confounding SNV
interpretation.
One gene identified in the NTC subtype, Eya2, stood out for
further examination. Eya2 exhibits strong GxE interactions and
is expressed in the cranial placodes, branchial arches and the
CNS during organogenesis (Xu et al., 1997), areas known to be
affected clinically in FAS/FASD. There are three alternative tran-
scriptional start sites associated with Eya2. To ensure complete
analysis, we examined the most proximal 5 kb from all three pro-
moters. The genomic signature profile demonstrates that there
are 21 SNVs (seven are in dbSNP Build 138) between C57BL/6NJ
and DBA/2NJ within the three promoters (see Table 3). Table 3
provides the genomic location of each SNV, its relative position
within the locus and the allele frequency. In addition, Table 3
shows the genomic sequence surrounding each SNV and illus-
trates changes in putative transcription factor (TF) binding sites
and CpG dinucleotides.
Sixteen of the twenty-one SNVs identified in the three pro-
moters of Eya2 potentially lead to the loss or gain of putative
transcription factor (TF) binding sites. For example, there are
no predicted TF binding sites at SNVs 1, 4, 7, 10, 13, 14, and
16 in the C57BL/6NJ allele, while SNVs 4, 7, 10, 13, and 16
are predicted to contain one or more TF binding sites in the
DBA/2J allele. Given the potential for these SNVs to function not
only in a genetic manner, but also epigenetically through alter-
ations in DNA methylation, we report that 5 of the 21 SNVs
within the three promoters of Eya2 change a CpG dinucleotide.
Four of these (SNV 2, 4, 21, and 22) lead to the loss of a CpG
dinucleotide in the DBA/2J background. Examination of puta-
tive TF binding sites in these four SNVs shows that there are
fewer potential TF binding sites in the C57BL/6NJ allele com-
pared to the DBA/2J allele. Eya2 shows increased expression in
C57BL/6NHsd embryos following alcohol treatment, while the
DBA/2NHsd animals exhibit a decrease in expression following
alcohol exposure. This would be consistent with increased TF
binding in C57BL/6NHsd embryos compared to DBA/2NHsd
cultures, and provides a putative mechanism for the GxE
interactions.
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Similar SNV analyses of the other 15 genes are documented
in the Supplemental Files (Table S1). There are four genes that
show strong GxE interactions that also have SNVs within the
proximal promoter: Apold1 (Apolipoprotein L domain contain-
ing 1), Leo1 (Paf1/RNA Polymerase II Complex Component),
Psme4 (Proteasome Activator Subunit 4) and Snord38a (Small
nucleolar RNA, C/D box 38A) (Table 2). Apold1 is thought to
be involved in angiogenesis in the brain vasculature (Diez-Roux
et al., 2011; Zhou et al., 2013); Leo1, which important in chro-
matin remodeling, is involved in neural crest development (Wertz
and Herrmann, 2000); Psme4 is a component of the proteasome
that specifically targets histones for degradation following DNA
damage (Ustrell et al., 2002; Qian et al., 2013); and Snord38a is
a C/D box small nucleolar RNA that is important for 2′O-ribose
methylation of rRNAs (Nicoloso et al., 1996).
A summary of the putative regulatory implications of these 241
SNVs is found in Table 4. Ten genes were found in the NTC sub-
type, while six were detected in the NTO embryos. Out of the
241 SNVs identified between C57BL/6NJ and DBA/2J, 186 have
the possibility to alter TF binding sites, while 62 cause the addi-
tion or removal of a CpG dinucleotide. Out of the 62 SNVs that
lead to CpG changes, 34 (55%) led to the loss of a CpG dinu-
cleotide, 26 (42%) led to the de novo creation of a CpG site and 2
(3%) changed the position of a CpG site (i.e., CCG to CGG). In
addition, the vast majority of SNVs that alter a CpG site [53/62
(85%)] are associated with potential additions, losses and/or sub-
stitutions in TF binding sites, indicating that both genetic (SNVs)
and epigenetic (CpGmethylation) could be implicated in the GxE
interactions.
To better understand the genetic variability between
the C57BL/6 sub-strains used for gene expression studies
(C57BL/6NHsd) and SNV analysis (C57BL/6NJ), we used the
SNV Data from the Broad Institute (Broad2) to identify SNVs
between C57BL/6NHsd and C57BL/6NJ in the “Compare Two
or More Strains” option from the Mouse Phenome Database
(http://phenome.jax.org/db/q?rtn=strains/search&compare2=1).
We discovered that there are 119590 SNVs between
C57BL/6NHsd and C57BL/6NJ, which given a genome of
∼ 2.7 × 109 bp, corresponds to a mutation frequency of
4.4 × 10−5 mutations/bp, or one SNV in every ∼22,500 bp.
In this study, we analyzed 5000 bp from 18 promoters of 16
genes, including three promoters for Eya2. This totals 90,000 bp
of sequence. Given a mutation frequency of 4.4 × 10−5, we
would expect to find four SNVs that could be attributed to
background alterations between C57BL/6NHsd and C57BL/6NJ
in our sample. Although we need to estimate the background
mutation frequency between DBA/2NHsd (expression studies)
and DBA/2NJ (SNV analysis), the DBA/2NHsd line has not been
sequenced nor has it been included in any of the available SNP
chip repositories. Therefore, we assumed a similar mutation
frequency between the two DBA/2 lines (i.e., four mutations
in 90,000 bp). Taking these numbers as an estimate, we would
expect to find eight total SNVs (four for the C57BL/6 lines and
four for the DBA/2 lines) that could be due within sub-line
mutations. However, we found 241 SNVs between C57BL/6NJ
and DBA/2J in this study, which corresponds to a mutation
frequency of 2.7 × 10−3 mutations/bp, indicating that likelihood
of seeing a GxE interaction due to false positives (∼0.033) falls
within a 0.05 confidence interval.
DISCUSSION
This study was conducted to better understand the genetic under-
pinnings underlying the susceptibility to alcohol exposure during
fetal development. We pursued this by identifying the intersected
set of genes that: (1) Are differentially expressed in response to
alcohol treatment during neurulation; and (2) Demonstrate a
genetic interaction between two strains of mice (C57BL/6 and
DBA/2) that respond very differently to prenatal alcohol expo-
sure. While C57BL/6 animals are highly sensitive to the terato-
genic effects of alcohol, DBA/2 animals are remarkably resistant,
as shown by studies using gavage feeding (Gilliam et al., 1988;
Downing et al., 2009, 2012) and our prior work in cultured
embryos that found alcohol-vulnerability in C57BL/6 embryo
cultures exposed to a short alcohol incubation period (Ogawa
et al., 2005; Chen et al., 2011; Zhou et al., 2011).
These comparative expression studies reveal a cohort of∼1400
genes that are preferentially expressed in either the C57BL/6NHsd
or DBA/2NHsd strains during the beginning stages of neurula-
tion. These genes may represent a first tier contribution to either
protect (DBA/2NHsd) or increase (C57BL/6NHsd) the vulnera-
bility of the embryo to the effects of alcohol exposure. Because
this set of transcripts does not take alcohol exposure into consid-
eration (e.g., C57BL/6NHsd ± EtOH vs. DBA/2NHsd ± EtOH),
it represents the cohort of transcripts that differ between these
two strains in two independent experiments. Genes of particular
interest are the neural transcription factor and homeobox genes
(Nkx1-2, Sox21, Igf1, and Gbx2), as they can mediate neural pro-
genitor cell fate determination and neural tube patterning. The
potassium channel (Kcnmb1) and cholinergic receptor (Chnb1)
genes can mediate timely signal transduction during neural dif-
ferentiation, while Hist1h2ab and Setd7 have the potential to dif-
ferentially affect the epigenetic response of the developing brain
cells to environmental assaults, including alcohol. The apoptosis,
cell cycle and heat shock proteins act to influence cell number, and
could contribute to neural tube deficits between the two lines.
For stringent comparison, the closed neural tube (NTC) and
open neural tube (NTO) embryonic subtypes were analyzed
independently, with an FDR of 5% as the cut off. These differen-
tially expressed genes potentially network to alter inflammatory
response, cell death and survival, energy production, embryonic
development and hematopoiesis between the two inbred lines.
This cohort of differentially expressed transcripts likely results
from combinations of factors including genetic background,
innate programming, reactivation of transposable elements and
epigenetic inheritance and responses. Since this study was con-
ducted on embryonic cultures, it eliminates maternal elements
(e.g., physiology, maternal care, circulation factors) that would
have normally acted during this critical developmental window.
However, since we analyzed whole brains, we were not able to
assess tissue-specificity or cell-specific differences in gene expres-
sion, and it is plausible that we missed rare transcripts with large
effects or primary cell-specific transcripts that are driving the
genetic differences in the sensitivity of these two inbred strains
to alcohol exposure. Therefore, it is likely that our results are
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Table 4 | Summary of the potential regulatory effects of the SNVs between C57BL/6NJ and DBA/2J in genes demonstrating GxE interactions.
NTC/ Symbol Gene MMU Coordinates Strand B6/D2 Altered Potential epigenetic gene regulation changes
NTO SNV TFB
CpG Change CG to NN NN to CG Altered TFB
NTC Csmd3 CUB and Sushi
multiple domains 3
15 47412184-
48623535
Reverse 11 8 1 0 1 1
NTC Eya2 Eyes Absent
Homolog2
(Drosophila)
2 165420528-
165597131
Forward 21 16 5 4 1 4
NTC Fam174b Membrane protein
FAM174B precursor
7 80885193-
80921805
Forward 1 0 0 0 0 0
NTC Mageb18 Melanoma-
associated antigen
B18
X 89364218-
89844911
Forward 1 1 0 0 0 0
NTC Mcat Malonyl CoA:ACP
Acyltransferase
(Mitochondrial)
15 83377227-
83386141
Reverse 54 42 12 6 5 9
NTC Pdxp Pyridoxal phosphate
phosphatase
15 78744349-
78749947
Forward 18 14 9 5 4 8
NTC Rpl36a 60S ribosomal
protein L36a
X 131120193-
131122601
Forward 3 2 1 1 0 1
NTC Tac2 Tachykinin-2 10 127162448-
127168824
Forward 9 7 3 1 2 3
NTC Tspan2 Tetraspanin-2 3 102538693-
102576233
Forward 1 1 0 0 0 0
NTC Zfp157 Zinc finger protein
157
5 138882704-
138901922
Forward 5 3 2 2 0 1
NTO Apold1 Apolipoprotein L
Domain Containing 1
6 134932019-
134936854
Forward 51 43 12 6 6 11
NTO Leo1 Paf1/RNA
Polymerase II
Complex Component
9 75289331-
75314239
Forward 6 6 3 1 2 3
NTO Psme4 Proteasome
(Prosome,
Macropain) Activator
Subunit 4
11 30671775-
30780361
Forward 16 10 2 1 1 2
NTO Snord38a Small nucleolar RNA,
C/D box 38A
4 116827121-
116827179
Reverse 32 24 8 4 3 7
NTO Vipr1 Vasoactive Intestinal
Peptide Receptor 1
9 121551834-
121582072
Forward 8 6 3 2 1 2
NTO Vps51 Vacuolar protein
sorting 51
19 6067842-
6077187
Reverse 4 3 1 1 0 1
Total 241 186 62 34 26 53
an under-representation of the total number of genes that are
differentially expressed between these two lines.
Genes exhibiting GxE interactions demonstrate differential
expression that inversely correlates with genotype and exposure
to the environmental factor (i.e., alcohol). With an FDR of 5%,
we identified 35 genes that exhibited GxE interactions, as mea-
sured by an inverse correlation in gene expression (based on
genotype) in response to alcohol. Examination of potential mech-
anisms for GxE interactions indicates that 16 genes have SNVs
in their proximal promoters. Several of these 16 candidates are
strongly associated with brain and cranial development, includ-
ing preplacedal ectoderm differentiation (Eya2) (Xu et al., 1997;
Grifone et al., 2007; Sato et al., 2010), cardiac and neural crest
development (Leo1) (Wertz and Herrmann, 2000), neuronal sur-
vival (Vipr1) (Delgado et al., 1996; Fabricius et al., 2011) and
oligodendryocyte differentiation (Tspan2) (Birling et al., 1999;
Diez-Roux et al., 2011). Others are implicated in behavioral disor-
ders including autism spectrum disorders (Csmd3 and Fam147b)
(Shimizu et al., 2003; Floris et al., 2008; Diez-Roux et al., 2011;
Sarahan et al., 2011; Kamien et al., 2014), Amytrophic Lateral
Sclerosis (Rps36a) (de Oliveira et al., 2013) and pain modula-
tion (Tac2) (Mar et al., 2012). Three genes in the NTO subtype
are involved in gene regulation, Leo1 (chromatin structure and
gene regulation;Wertz and Herrmann, 2000), Psme4 (proteasome
www.frontiersin.org June 2014 | Volume 5 | Article 173 | 11
Lossie et al. Genomic signatures underlying alcohol susceptibility
degradation of histones; Ustrell et al., 2002; Qian et al., 2013)
and Snord38a (modifications of ribosomal RNA; Nicoloso et al.,
1996). Although it is not clear if there are any specific pathways
that are affected by these four genes, several have the ability to
disrupt expression and protein function on a global scale. Most
of these are downregulated in C57BL/6NHsd animals following
alcohol exposure, indicating that global disruption to the pro-
teasome pathway, chromatin remodeling and rRNA methylation
may be a factor in the increased developmental delay in the NTO
embryonic cultures.
It is becoming increasingly clear that phenotypic variability
and causative lesions are not restricted to the protein-coding
regions of the genome. Several GWAS studies have demonstrated
that SNVs in non-coding regions of the DNA are strongly associ-
ated with disease processes (De Gobbi et al., 2006; Enjuanes et al.,
2006; Choi et al., 2009; Glinskii et al., 2009; Heckmann et al.,
2010; Maceachern et al., 2011a,b; Brown et al., 2013; Fan et al.,
2013; Perumbakkam et al., 2013; Renteria et al., 2013).
To understand the possible regulatory consequences associ-
ated with these gene expression changes, we took this analysis
one step further by cataloging the SNVs between the parental
strains in the promoter regions of the 35 genes and determining
potential regulatory changes associated with the SNVs. Sixteen of
these genes had a least one SNV in the proximal promoter (i.e.,
within 5 kb of the transcriptional start site), for a total of 241
SNVs within 90,000 bp of promoter sequence. The majority of
SNVs (77%; 186/241) altered the genomic DNA in a way that led
to the predicted addition or subtraction or a potential transcrip-
tion factor binding site, indicating that these underlying genetic
differences could play significant roles in the differential pheno-
types we detected in this study. In addition, ∼25% (62/241) of
the SNVs have the potential to affect DNA methylation by either
creating or eliminating a CpG dinucleotide. Since DNA methy-
lation is affected by alcohol exposure in utero (Ramsay, 2010;
Laufer et al., 2013; Resendiz et al., 2013; Ungerer et al., 2013) and
epigenetic gene regulation is critical for neuronal development
(Chen et al., 2014), the underlying genetic differences between
the C57BL/6 and DBA/2 inbred strains that impact CpG din-
ucleotides could create epigenetic consequences that predispose
the C57BL/6 embryos to the teratogenic effects of alcohol, while
protecting DBA/2 from this vulnerability.
CONCLUSIONS
By using a multi-pronged approach in two separate experiments
(neural tube open and neural tube closed phenotypes), we cap-
tured over 900 genes that have the potential to contribute to the
cascade that leads to differential dysmorphology in embyros from
the two genetically contrasting lines. These first tier genes are
good candidates for further understanding the phenotypic vari-
ability associated with in utero alcohol exposure. Exploration of
the genetic and environmental factors led us to a cohort of 35
genes subject to GxE interactions; these genes represent the best
candidates for driving the downstream morphological changes
observed following alcohol exposure. Examination of potential
regulatory SNVs associated with these 35 candidates indicates
that the differences between the C57BL/6 and DBA/2 inbred
strains could be due to a variety of factors, including binding
of cis-acting elements (e.g., transcription factors), expression of
trans-acting factors, epigenetic events, evolutionary consequences
and combinations of these different factors.
These experiments lay the groundwork for future studies
aimed at testing the causality of these different SNVs. Although
a seemingly daunting task, with emerging genome modification
tools, such as zinc finger, TALEN and CRISPR modification sys-
tems (Gaj et al., 2013) under development and refinement, it
may be possible to start systematically disrupting multiple SNVs
with exquisite sensitivity. Other possible approaches include using
selection to screen for animals containing the most predictive
SNVs and determining which cohorts of SNVs recapitulate the
susceptible phenotype in the resistant DBA/2NHsd population.
Studies in chicken demonstrate the feasibility and elegance of
this approach (Maceachern et al., 2011a,b; Perumbakkam et al.,
2013). Although we cannot rule out that the alterations in gene
expression are not due to the SNVs identified here, this study pro-
vides the top 35 genes showing GxE interactions following alcohol
exposure, providing a strong platform for future studies aimed
at understanding the roles of these genetic and transcriptional
changes associated with vulnerability to the teratogenic effects of
fetal alcohol exposure.
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Figure S1 | Gene x Environment interactions of the genes identified in the
embryos with closed neural tubes (NTC). The Affymetrix PLIER
expression levels are shown on the Y-axis. The black circles represent
gene expression levels in control embryos, while the triangles represent
gene expression levels in the alcohol-treated animals. Two conditions are
measured in this experiment, gene expression levels in controls and gene
expression levels in EtOH-treated animals. The blue line depicts the
changes in gene expression found between the C57BL/6NHsd control
embryos (black circle) and their EtOH-treated test embryos (black
triangle). The red line depicts the changes in in gene expression found
between the DBA/2NHsd control embryos (black circle) and their
EtOH-treated test embryos (black triangle). The interaction is depicted by
showing an inverse correlation between the gene expression profiles of
the two inbred strains.
Figure S2 | Gene x Environment interactions of the genes identified in the
embryos with open neural tubes (NTO). The Affymetrix PLIER expression
levels are shown on the Y-axis. The black circles represent gene
expression levels in control embryos, while the triangles represent gene
expression levels in the alcohol-treated animals. Two conditions are
measured in this experiment, gene expression levels in controls and gene
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expression levels in EtOH-treated animals. The blue line depicts the
changes in gene expression found between the C57BL/6NHsd control
embryos (black circle) and their EtOH-treated test embryos (black
triangle). The red line depicts the changes in in gene expression found
between the DBA/2NHsd control embryos (black circle) and their
EtOH-treated test embryos (black triangle). The interaction is depicted by
showing an inverse correlation between the gene expression profiles of
the two inbred strains.
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